Search
QuidelOrtho Corp
QDELAdd to Watchlist
18.250USD
+0.070+0.39%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.24BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.39%
5 Days
+32.34%
1 Month
+19.28%
6 Months
-36.59%
Year to Date
-36.10%
1 Year
-39.55%
Key Figures
18.510Open
18.650High
1.22MVolume
LossP/E TTM
7.16P/E Dynamic
--Dividend TTM
1.80%Turnover Ratio
18.180Prev. Close
17.830Low
16.50MTurnover
LossP/E Static
0.67P/B
0.00%Div Yield TTM
-20.03%ROA
35.57552wk High
0.71Volume Ratio
-2.05BNet Profit
68.10MShares
-17.8511EPS TTM
0.77Beta
-49.95%ROE
9.92052wk Low
4.51%Amplitude
35.01%Gross Margin
1.24BMarket Cap
4.38Reward/Risk
4.30%Risk Rate
TradingKey Stock Score of QuidelOrtho Corp
Currency: USD Updated: 2026-07-02Key Insights
QuidelOrtho Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 88 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 21.17.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
QuidelOrtho Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
QuidelOrtho Corp Highlights
StrengthsRisks
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.73B.
Overvalued
The company’s latest PE is -1.02, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.33M shares, decreasing 13.83% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 312.25K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.45.
Analyst Rating
Based on
4
analysts
Hold
Current Rating
21.167
Target Price
+16.43%
Upside Space
QuidelOrtho Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
QuidelOrtho Corp Info
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Ticker SymbolQDEL
CompanyQuidelOrtho Corp
CEOBlaser (Brian J)
Websitehttps://www.quidelortho.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of QuidelOrtho Corp (QDEL)?
The current price of QuidelOrtho Corp (QDEL) is 18.25.
What is the symbol of QuidelOrtho Corp?
The ticker symbol of QuidelOrtho Corp is QDEL.
What is the 52-week high of QuidelOrtho Corp?
The 52-week high of QuidelOrtho Corp is 35.58.
What is the 52-week low of QuidelOrtho Corp?
The 52-week low of QuidelOrtho Corp is 9.92.
What is the market capitalization of QuidelOrtho Corp?
The market capitalization of QuidelOrtho Corp is 1.24B.
Is QuidelOrtho Corp (QDEL) currently rated as Buy, Hold, or Sell?
According to analysts, QuidelOrtho Corp (QDEL) has an overall rating of signal_hold, with a price target of 21.17.
What is the Earnings Per Share (EPS TTM) of QuidelOrtho Corp (QDEL)?
The Earnings Per Share (EPS TTM) of QuidelOrtho Corp (QDEL) is -16.69.